AACR 2021: Neoadjuvant nivolumab plus chemotherapy increased pathological complete response rate in CheckMate-816 lung cancer trial
Adding nivolumab to chemotherapy as neoadjuvant treatment for patients with resectable non-small cell lung cancer…
Browsing: nivolumab immunotherapy
Nivolumab immunotherapy safe, feasible during chemoradiation for advanced head and neck cancer
Analysis of a clinical trial, RTOG Foundation 3504, finds that nivolumab immunotherapy can be administered…